Clinical Trials Directory

Trials / Conditions / Squamous Cell Carcinoma, Head And Neck

Squamous Cell Carcinoma, Head And Neck

9 registered clinical trials studyying Squamous Cell Carcinoma, Head And Neck — 1 currently recruiting.

StatusTrialSponsorPhase
RecruitingIntratumoral Delivery of Viral Replicon (saRNA) Particles Expressing IL-12 in Head and Neck Cancer
NCT06736379
VLP TherapeuticsPhase 1
CompletedSitravatinib (MGCD516) and Nivolumab in Oral Cavity Cancer Window Opportunity Study
NCT03575598
University Health Network, TorontoEARLY_Phase 1
WithdrawnPre-operative Mocetinostat (MGCD0103) and Durvalumab (MEDI4736) (PRIMED) for Squamous Cell Carcinoma of the Or
NCT02993991
University Health Network, TorontoPhase 1
WithdrawnStudy Comparing AlloVax™ to Chemotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head & Neck
NCT02624999
Mirror Biologics, Inc.Phase 2
CompletedFiclatuzumab and Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)
NCT02277197
James J LeePhase 1
CompletedMitomycin C in Patients With Incurable p16 Positive Oropharyngeal and p16 Negative Head and Neck Squamous Cell
NCT02369458
Washington University School of MedicinePhase 2
CompletedImmunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell Carcinoma
NCT02296684
Washington University School of MedicinePhase 2
TerminatedSafety and Efficacy of Radiation/Cetuximab Plus EGFR Antisense DNA for Head and Neck Squamous Cell Carcinoma
NCT00903461
University of PittsburghPhase 1
WithdrawnA Phase II Trial Evaluating WNT974 in Patients With Metastatic Head and Neck Squamous Cell Carcinoma
NCT02649530
University of Michigan Rogel Cancer CenterPhase 2